-+ 0.00%
-+ 0.00%
-+ 0.00%

Cantor Fitzgerald Initiates Coverage On Candel Therapeutics with Overweight Rating

Benzinga·04/20/2026 15:08:44
Listen to the news
Cantor Fitzgerald initiates coverage on Candel Therapeutics (NASDAQ:CADL) with a Overweight rating.